Skip to main content
Premium Trial:

Request an Annual Quote

Douglas Brutlag

Sure Genomics, a personal genetics company, said today that Douglas Brutlag, professor emeritus of biochemistry & medicine at the Stanford University School of Medicine, has formally joined the company's advisory board.

Brutlag has a Ph.D in biochemistry with great distinction from Stanford University, which he received in 1972. He has been a professor of biochemistry at the university since 1974. Also, he was a co-founder of IntelliGenetics, one of the first firms involved in bioinformatics, and he co-founded the International Society for Computational Biology. Brutlag has also served on the scientific advisory boards of many firms and organizations, including the National Library of Medicine and the Max Planck Institute. 

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.